BernhardJosefHeringMD
Internal Medicine • Minneapolis, MNProfessor, Surgery, University of Minnesota Medical School. Preventative Cardiology
Are you Dr. Hering?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 12 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
516 Delaware Street SE
PWB First floor Clinic 1e UNIV of Minn Physicians
Minneapolis, MN 55455Phone+1 612-626-6666Fax+1 612-625-8496
Summary
- Dr. Bernhard Hering, MD is an internist in Minneapolis, Minnesota. He is currently licensed to practice medicine in Minnesota. He is affiliated with M Health Fairview University of Minnesota Medical Center and is a Professor at University of Minnesota Medical School. Preventative Cardiology.
Education & Training
University of Giessen Faculty of MedicineClass of 1983
Certifications & Licensure
MN State Medical License 1998 - 2025
Clinical Trials
- MGA031, Sirolimus and Tacrolimus in Islet Transplantation Start of enrollment: 2005 Nov 01
- hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients Start of enrollment: 2000 Apr 01
- Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes Start of enrollment: 2000 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 402 citationsPhase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe HypoglycemiaBernhard J. Hering, William R. Clarke, Nancy D. Bridges, Thomas L. Eggerman, Rodolfo Alejandro
Diabetes Care. 2016-04-18 - 59 citationsReport of the Key Opinion Leaders Meeting on Stem Cell-derived Beta CellsJon S. Odorico, James F. Markmann, Douglas A. Melton, Julia L. Greenstein, Albert Hwa
Transplantation. 2018-08-01 - 118 citationsNational Institutes of Health–Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing FacilitiesCamillo Ricordi, Julia S. Goldstein, Appakalai N. Balamurugan, Gregory L. Szot, Tatsuya Kin
Diabetes. 2016-11-01
Press Mentions
Penn Study Proves Promising for Type 1 Diabetes CureSeptember 14th, 2020- Penn Researchers Advance Potential Cure for Type 1 DiabetesSeptember 8th, 2020
Researchers Remove the Need for Anti-Rejection Drugs in Transplant RecipientsAugust 5th, 2019- Join now to see all
Grant Support
- Efalizumab (RAPTIVA) Combined With Sirolimus In Type 1 Diabetic Islet AllograftNational Center For Research Resources2009
- Clinical Trial: Hokt3g1 (Ala-Ala), Sirolimus And Low Dose Tacrolimus Therapy InNational Center For Research Resources2009
- PIG To Non-Human Primate Islet XenograftsNational Institute Of Allergy And Infectious Diseases2008–2009
- Cit-03: Single-Center, Open-Label Clinical Trial Of The Efficacy Of PeritransplaNational Center For Research Resources2007–2009
- Screening Procedure For Allo-Islet Transplantation ProtocolsNational Center For Research Resources2006–2009
- Clinical Trial: Hokt3Î|1 (Ala-Ala), Sirolimus And Low Dose Tacrolimus TheraNational Center For Research Resources2008
- Human Pancreatic Islet Cell ResourcesNational Center For Research Resources2006–2008
- Advancing Islet Transplants For Type 1 Diabetes CareNational Institute Of Allergy And Infectious Diseases2004–2008
- Cts-Ipita-Ixa 2007 Joint ConferenceNational Institute Of Allergy And Infectious Diseases2007
- Hokt3γ1 (Ala-Ala), Sirolimus And Low Dose Tacrolimus Therapy In Type 1 DiabNational Center For Research Resources2007
- Islet Transplantation In Type 1 Diabetic Patients Using The Edmonton ProtocolNational Center For Research Resources2004–2007
- Anti-Thymoglobumlin, Cyclosporin And RAD In Islet TransplantNational Center For Research Resources2004–2007
- Preclinical Models Of Organ &Cell Transplant ToleranceNational Institute Of Diabetes And Digestive And Kidney Diseases2006
- Mixed Chimerism In Haploidentical Non-Human PrimatesNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
- Human Pancreatic Islet Cell Resources (ICRS)National Center For Research Resources2001–2006
- Initial VS Delayed Mycophenolate Mofetil In Single-Donor Islet AllotransplantatNational Center For Research Resources2005
- Human Pancreatic Islet Cell Resources Type 1 DiabetesNational Center For Research Resources2004–2005
- Hokt3gammal (Ala-Ala) For The Prevention Of Human Islet Allograft FailureNational Center For Research Resources2004–2005
- Tolerance To Islet Allografts In Type I DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2005
- Initial Vs. Delayed Mycophenolate Mofetil In Single-Donor Islet AllotransplantanNational Center For Research Resources2004
- Immunotherapy And Islet Replacement In Early DiabetesNational Center For Research Resources2000–2002
